Rite Aid Corp. (NYSE: RAD) has managed to turn from something that looks and smells bad into Shinola over the past year. This troubled drug store chain's stock price is now back above $5.00, and it was just outside of the screen criteria in April. What is hard to imagine here is that the company has managed to get back to profitability and the stock has risen some 200% since early April. Rite Aid shares even traded under $1 last December, its key holder is no longer a dominating force and same-store sales are positive again now that drugs and other prescriptions are helping out. If the company can ever get its front-end retail same-store sales consistently up, then there may even be more room to run. We would point out that the consensus analyst price target is lower at $5.01 for the next year.